DMAC vs PDD · $157.4M cap vs P/E 8.4, rev $61.75B
DiaMedica Therapeutics Inc (DMAC) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
DMAC does not have a complete income-statement cache yet.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
DMAC currently screens at market cap $157.4M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the DMAC and PDD stock pages for the full models.
Not investment advice.